| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.233 | 54.588 | 58.923 | 60.141 | 98.783 |
| Total Income - EUR | - | - | - | - | - | 7.233 | 54.588 | 58.923 | 60.141 | 98.809 |
| Total Expenses - EUR | - | - | - | - | - | 6.779 | 41.530 | 41.812 | 52.544 | 71.023 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 454 | 13.058 | 17.111 | 7.597 | 27.785 |
| Net Profit/Loss - EUR | - | - | - | - | - | 454 | 12.589 | 16.522 | 7.085 | 25.236 |
| Employees | - | - | - | - | - | 0 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Moldis Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 2.865 | 3.741 | 3.838 | 11.883 | 28.073 |
| Current Assets | - | - | - | - | - | 10.289 | 10.327 | 26.964 | 26.001 | 37.217 |
| Inventories | - | - | - | - | - | 5.651 | 3.679 | 4.213 | 14.204 | 16.623 |
| Receivables | - | - | - | - | - | 0 | 2.568 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | 4.638 | 4.081 | 22.750 | 11.797 | 20.593 |
| Shareholders Funds | - | - | - | - | - | 496 | 13.074 | 29.636 | 36.632 | 61.663 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 12.658 | 994 | 1.166 | 1.252 | 3.627 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Moldis Med S.r.l.